Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Removing both ovaries treated the woman's excess male hormone symptoms.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Prostaglandins may protect hair follicles during chemotherapy.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

The treatment was not recommended due to limited effectiveness and significant side effects.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Combination drug therapy improves hair growth and patient care for androgenetic alopecia.

Some chemotherapy can cause permanent hair loss.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

More research is needed to understand chemotherapy-induced hair loss and its phases.

FDG PET/CT scans can change cancer treatment plans for dogs.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Biological therapy boosts the immune system to effectively fight melanoma.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Hair loss from cervical cancer treatment needs better prevention and management.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.